EIF2A and gastric cancer: Wu SF and Li ZJ (2019) reported that allicin (12, 24, 48 μg/mL for 24, 48, 72 h) inhibited the proliferation of GC cells SGC-7901and promoted their apoptosis by dose-dependently increasing the expression of GRP78, PERK, p-PERK, eIF2a, ATF-4 and CHOP.